Amarantus Bioscience Holdings, Inc.
company.status.inactiveCIK 1424812fmd_1CR789X6ADCQXS124RPG9H469PManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 14, 2008 to Mar 31, 2016, 26 periods
Latest annual · FY2012
Millions- Total revenues
- 0
- Operating income
- (25)
- Net income
- (25)
- Free cash flow
- (16)
Latest quarter · Q1 FY2016
Millions- Operating income
- (3)
- Net income
- (2)
- Free cash flow
- (2)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2010 to FY2015
- n/m
Amarantus Bioscience Holdings, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Operating income | -$24.8 million | -$21.4 million | 10-K 2016-05-16 · proof | |
| Net income | -$25.2 million | -$27.3 million | 10-K 2016-05-16 · proof | |
| Cash from operating activities | -$16 million | -$11.3 million | 10-K 2016-05-16 · proof | |
| Free cash flow | -$16 million | -$11.5 million | 10-K 2016-05-16 · proof | |
| Total assets | $11.7 million | $2.3 million | +417.5% | 10-Q 2016-06-01 · proof |
| Total liabilities | $17.2 million | $6.3 million | +172.1% | 10-Q 2016-06-01 · proof |
| Cash and cash equivalents | $176,000 | $214,000 | -17.8% | 10-K 2016-05-16 · proof |
- What was Amarantus Bioscience Holdings, Inc.'s operating income in fiscal 2015?
- Amarantus Bioscience Holdings, Inc. reported operating income of -$24.8 million for fiscal 2015 (the year ended Dec 31, 2015), against -$21.4 million the year before. Source: the 10-K filed with the SEC on May 16, 2016. SEC
- What was Amarantus Bioscience Holdings, Inc.'s net income in fiscal 2015?
- Amarantus Bioscience Holdings, Inc. reported net income of -$25.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$27.3 million the year before. Source: the 10-K filed with the SEC on May 16, 2016. SEC
- What was Amarantus Bioscience Holdings, Inc.'s cash from operating activities in fiscal 2015?
- Amarantus Bioscience Holdings, Inc. reported cash from operating activities of -$16 million for fiscal 2015 (the year ended Dec 31, 2015), against -$11.3 million the year before. Source: the 10-K filed with the SEC on May 16, 2016. SEC
- What was Amarantus Bioscience Holdings, Inc.'s free cash flow in fiscal 2015?
- Amarantus Bioscience Holdings, Inc. reported free cash flow of -$16 million for fiscal 2015 (the year ended Dec 31, 2015), against -$11.5 million the year before. Source: the 10-K filed with the SEC on May 16, 2016. SEC
- What are Amarantus Bioscience Holdings, Inc.'s total assets?
- As of Dec 31, 2015, Amarantus Bioscience Holdings, Inc. reported total assets of $11.7 million, against $2.3 million a year earlier (+417.5%). Source: the 10-Q filed with the SEC on Jun 1, 2016 (restated). SEC
- What are Amarantus Bioscience Holdings, Inc.'s total liabilities?
- As of Dec 31, 2015, Amarantus Bioscience Holdings, Inc. reported total liabilities of $17.2 million, against $6.3 million a year earlier (+172.1%). Source: the 10-Q filed with the SEC on Jun 1, 2016 (restated). SEC
- What are Amarantus Bioscience Holdings, Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, Amarantus Bioscience Holdings, Inc. reported cash and cash equivalents of $176,000, against $214,000 a year earlier (-17.8%). Source: the 10-K filed with the SEC on May 16, 2016. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1424812&period_type=annual&limit=5"Information only, not investment advice.